WMSA
ARRY

Weiss Multi-Strategy Advisers’s Array Biopharma Inc ARRY Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-65,000
Closed -$1.58M – 691
2019
Q1 		$1.58M Sell
65,000
-5,000
-7% -$104K 0.04% 356
2018
Q4 		$998K Sell
70,000
-40,375
-37% -$612K 0.04% 299
2018
Q3 		$1.68M Sell
110,375
-9,625
-8% -$147K 0.04% 351
2018
Q2 		$2.01M Sell
120,000
-20,000
-14% -$318K 0.05% 341
2018
Q1 		$2.29M Sell
140,000
-35,000
-20% -$561K 0.07% 301
2017
Q4 		$2.24M Buy
175,000
+2,500
+1% +$28.4K 0.06% 317
2017
Q3 		$2.12M Buy
172,500
+32,500
+23% +$302K 0.08% 299
2017
Q2 		$1.17M Hold
140,000
– – 0.05% 339
2017
Q1 		$1.25M Buy
140,000
+5,000
+4% +$53.2K 0.05% 362
2016
Q4 		$1.19M Hold
135,000
– – 0.06% 270
2016
Q3 		$911K Sell
135,000
-7,155
-5% -$27.7K 0.06% 300
2016
Q2 		$506K Sell
142,155
-97,845
-41% -$319K 0.04% 323
2016
Q1 		$708K Hold
240,000
– – 0.03% 362
2015
Q4 		$1.01M Buy
240,000
+10,000
+4% +$45.6K 0.07% 239
2015
Q3 		$1.05M Buy
230,000
+23,000
+11% +$136K 0.05% 255
2015
Q2 		$1.49M Buy
207,000
+500
+0.2% +$3.69K 0.06% 285
2015
Q1 		$1.52M Buy
206,500
+6,500
+3% +$46.3K 0.07% 275
2014
Q4 		$946K Sell
200,000
-5,000
-2% -$19.8K 0.03% 288
2014
Q3 		$732K Buy
205,000
+20,000
+11% +$78.8K 0.02% 411
2014
Q2 		$844K Buy
185,000
+40,000
+28% +$165K 0.02% 440
2014
Q1 		$682K Sell
145,000
-38,150
-21% -$192K 0.01% 568
2013
Q4 		$918K Sell
183,150
-16,850
-8% -$91.7K 0.02% 456
2013
Q3 		$1.24M Sell
200,000
-60,000
-23% -$356K 0.03% 387
2013
Q2 		$1.18M Buy
+260,000
New +$1.4M 0.03% 369

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Weiss Multi-Strategy Advisers's ARRY Position: Q2 2019 in Review

Weiss Multi-Strategy Advisers sold out of Array Biopharma Inc (ARRY) in Q2 2019, closing a stake of 65,000 shares — an estimated $1.58M sold.

Weiss Multi-Strategy Advisers first reported a position in ARRY in Q2 2013 and held it in 24 quarters. The position peaked at $2.29M in Q1 2018. 319 funds tracked by Wall St. Rank hold ARRY as of Q2 2019.

  • Weiss Multi-Strategy Advisers reported no remaining Array Biopharma Inc position as of Q2 2019 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 65,000 Array Biopharma Inc shares in Q2 2019, an estimated $1.58M.
  • Weiss Multi-Strategy Advisers first reported a position in Array Biopharma Inc in Q2 2013 and held it in 24 quarters.
  • Weiss Multi-Strategy Advisers's Array Biopharma Inc position peaked at $2.29M in Q1 2018.
  • 319 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2019.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.